Senator Charles Grassley (R) hopes he can get his bipartisan legislation to reduce prescription drug prices passed in the new administration.

Grassley reintroduced the Prescription Drug Pricing Reduction Act of 2020 last summer which he shares has had a bumpy journey, “Two years ago, when I was chairman of the Finance Committee we got a bill to reduce prescription drugs out of committee and by a wide margin, 19-9. And we didn’t get it up because of opposition from Senator [Mitch] McConnell to begin with and then for political purposes [Senator Chuck] Schumer stepped in and told [Senator Ron] Wyden, my cosponsor, that he didn’t want to pass before the election. So I’m hoping that since President Biden’s got the same opinion on reducing prescription drugs as what Trump had that we’ll be able to move a bill.”

According to the independent Congressional Budget Office, this bill would save taxpayers $95 billion, reduce out-of-pocket spending by $72 billion, and reduce premiums by $1 billion. Grassley isn’t the only lawmaker to tackle prescription drug prices recently, as Senator Bernie Sanders (I) introduced a package of bills last month which includes a peg of the price of drugs in the U.S. to the median price in Canada, the United Kingdom, France, Germany, and Japan, and allows patients, pharmacists, and wholesalers to import medicine from Canada and other major countries.